Estradiol inhibits smooth muscle cell growth in part by activating the cAMP-adenosine pathway

Hypertension

Volumn 35, Issue 1 II, 2000, Pages 262-266

  Dubey, Raghvendra K ^a   Gillespie, Delbert G ^b   Mi, Zaichuan ^b   Rosselli, Marinella ^b   Keller, Paul J ^b   Jackson, Edwin K ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b NONE

Author keywords

Adenosine; Cyclic AMP; Hormones; Muscle, smooth; Receptors, adenosine; Vascular remodeling

Indexed keywords

1,3 DIPROPYL 8 (4 SULFOPHENYL)XANTHINE; 2',5' DIDEOXYADENOSINE; 8 (3,4 DIMETHOXYSTYRYL) 7 METHYL 1,3 DIPROPYLXANTHINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 9 (2 HYDROXY 3 NONYL)ADENINE; ADENOSINE; ADENOSINE A2 RECEPTOR; ADENOSINE DEAMINASE INHIBITOR; ADENOSINE KINASE INHIBITOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENYLATE CYCLASE; CYCLIC AMP; ESTRADIOL; FORSKOLIN;

ANIMAL CELL; AORTA MEDIA; CELL GROWTH; COLLAGEN SYNTHESIS; CONFERENCE PAPER; CONTROLLED STUDY; DNA SYNTHESIS; DRUG MECHANISM; DRUG SELECTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0033970881     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.35.1.262     Document Type: Conference Paper

References (14)

1. Rosselli M, Keller PJ, Kern F, Hahn AWA, Dubey RK. Estradiol inhibits mitogen-induced proliferation and migration of human aortic smooth muscle cells: implications for cardiovascular disease in women. Circulation. 1994;90:I-87. Abstract.
2. Dubey RK, Gillespie DG, Jackson EK, Keller P. Differential effects of clinically used estrogen(s) on mitogen-induced growth of human aortic smooth muscle cells. Hypertension. 1998;32:625. Abstract.
3. Foegh M, Asotra S, Howell M, Ramwell P. Estradiol inhibition of arterial neointimal hyperplasia after balloon injury. J Vasc Surg. 1994;14: 722-726.
4. Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan TR Jr, Lubahn DB, O'Donell TF Jr, Korach KS, Mendelsohn ME. Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nature Med. 1997;3:545-548.
5. 2b receptor. Hypertension. 1996;27:786-793.
6. Dubey RK, Mi Z, Gillespie DG, Jackson EK. cAMP-adenosine pathway inhibits vascular smooth muscle cell growth. Hypertension. 1996;28: 765-771.
7. Dubey RK, Gillespie DG, Mi Z, Suzuki F, Jackson EK. Smooth muscle cell-derived adenosine inhibits cell growth. Hypertension. 1996;27: 766-773.
8. Farhat MY, Abi-Younes S, Dingaan B, Vargas R, Ramwell PW. Estradiol increases cyclic adenosine monophosphate in rat pulmonary vascular smooth muscle cells by a nongenomic mechanism. J Pharmacol Exp Ther. 1996;276:652-657.
9. Jackson EK, Mi Z, Koehler MT, Carcillo JA Jr, Herzer WA. Injured erythrocytes release adenosine deaminase into the circulation. J Pharmacol Exp Ther. 1996;279:1250-1260.
10. Dubey RK, Gillespie DG, Jackson EK. cAMP-adenosine pathway induces nitric oxide synthesis in aortic smooth muscle cells. Hypertension. 1998;31:296-302.
11. Dubey RK, Jackson EK, Rupprecht HD, Sterzel RB. Factors controlling growth and matrix production in vascular smooth muscle and glomerular mesangial cells. Curr Opin Nephrol Hypertens. 1997;6:88-105.
12. Dubey RK, Mi Z, Gillespie DG, Jackson EK. cAMP-adenosine pathway inhibits glomerular mesangial cell growth. Hypertension. 1997;30:506. Abstract.
13. Dubey RK, Gillespie DG, Mi Z, Jackson EK. Cardiac fibroblasts metabolize cyclic-AMP to generate adenosine. Hypertension. 1996; 28:524. Abstract.
14. Oparil S, Levine RL, Chen YF. Sex hormones and the vasculature. In: Sowers JR, Walsh M, eds. Endocrinology of the Vasculature. Totwa, NJ; Humana Press, Inc; 1996:225-237.